3M Company (MMM) Financial Statements
Historical financial data — 41 statements covering FY2016–FY2025
3M, a multinational conglomerate founded in 1902, sells tens of thousands of products ranging from sponges to respirators. The firm is well known for its extensive research and development capabili...
3M Company's revenue increased 1.5% year over year, from $24.57B to $24.95B.
Net income decreased 22.1% over the same period, from $4.17B to $3.25B.
Over the 9-year period from FY2016 to FY2025, revenue declined by 17% in total.
Total debt remained relatively stable at $12.60B.
The debt-to-equity ratio stands at 2.68, indicating a high leverage profile.
Operating cash flow grew 26.8% to $2.31B.
3M Company maintains a healthy net profit margin of 13.0%.
Recent Financial Statements
| Period | Revenue | Net Income | Gross Profit | EBIT | Op. Cash Flow | Total Assets | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2023 | $24.67B+50.8% | $-7.94B | $10.87B | $-10.37B | $4.69B | $49.62B | $16.01B | $4.67B |
| Q1 FY2024 | $8.00B-67.6% | $928.0M | $3.67B | $1.50B | $767.0M | $55.24B | $21.41B | $4.87B |
| Q2 FY2024 | $12.27B+53.3% | $2.07B | $5.21B | $2.42B | $1.79B | $43.38B | $13.08B | $3.92B |
| Q3 FY2024 | $18.57B+51.3% | $3.44B | $7.86B | $3.74B | $1.0M | $40.88B | $13.19B | $4.64B |
| Q1 FY2025 | $5.95B-67.9% | $1.12B | $2.48B | $1.25B | $-79.0M | $39.95B | $13.48B | $4.46B |
| Q2 FY2025 | $12.30B+106.6% | $1.84B | $5.17B | $2.39B | $-1.03B | $37.99B | $13.15B | $4.29B |
| Q3 FY2025 | $18.82B+53.0% | $2.67B | $7.90B | $3.83B | $723.0M | $37.61B | $12.60B | $4.63B |
| Q1 FY2026 | $6.03B-68.0% | $653.0M | $2.46B | $1.40B | $574.0M | $35.44B | $12.56B | $3.26B |
Balance Sheet Summary (Latest Period)
Total Assets
$37.73B
Total Liabilities
$32.99B
Total Equity
$4.70B
Cash & Equivalents
N/A
Total Debt
$12.60B
Current Assets
$16.39B
Current Liabilities
$9.60B
Retained Earnings
$38.26B